Related Experiment Video
Updated: Jul 1, 2026
07:35
Hyperglycemic Clamp and Hypoglycemic Clamp in Conscious Mice
Published on: January 26, 2024
Relationship between hypomagnesemia and glucose homeostasis
Martina Montagnana1, Giuseppe Lippi, Giovanni Targher
1Sezione di Chimica Clinica, Dipartimento di Scienze Morfologico-Biomediche, Università di Verona, Italy. martina.montagnana@med.lu.se
Clinical Laboratory
|September 11, 2008
Summary
Magnesium levels are linked to blood sugar control. Low magnesium was more common in individuals with high fasting plasma glucose (FPG), suggesting a role in diabetes management.
Area of Science:
- Endocrinology
- Metabolic Research
- Clinical Biochemistry
Background:
- The interplay between magnesium metabolism and glucose homeostasis remains a subject of debate.
- Existing research presents conflicting findings regarding this relationship.
Purpose of the Study:
- To investigate the association between serum magnesium levels and fasting plasma glucose (FPG) in a large outpatient cohort.
- To determine if magnesium status influences glucose control, particularly in individuals with elevated FPG.
Main Methods:
- Retrospective analysis of serum magnesium and FPG test results from 7,659 outpatients aged over 35.
- Statistical analysis, including multivariable linear regression, to assess the association between magnesium and FPG.
Main Results:
- Hypomagnesemia was more prevalent in subjects with FPG > 7.0 mmol/L.
- A significantly higher frequency of hypomagnesemia was observed in individuals with elevated FPG levels (> 7.0 mmol/L).
- Multivariable regression confirmed a significant association between magnesium and FPG exclusively in patients with FPG > 7.0 mmol/L.
Conclusions:
- Magnesium metabolism appears to play a role in maintaining glucose homeostasis.
- This association is particularly relevant for patients exhibiting FPG levels indicative of potential diabetes.
Related Concept Videos
01:15Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
01:26Hypoglycemia
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
01:02Glucose Homeostasis: Regulation of Blood Glucose
Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
01:21Hyperosmolar Hyperglycemic State
Hyperosmolar Hyperglycemic State, or HHS, is a serious and life-threatening complication of type 2 diabetes mellitus. It is characterized by three main features: severe hyperglycemia, profound dehydration, and elevated serum osmolality, all occurring without significant ketoacidosis.HHS typically develops in older adults or individuals with limited access to fluids. This may result from illness, cognitive impairment, or medications such as diuretics or corticosteroids. These factors reduce...
01:22Diabetic Ketoacidosis ll: Pathophysiology
Diabetic ketoacidosis (DKA) is a metabolic emergency characterized by hyperglycemia, ketonemia, and metabolic acidosis. It results from severe insulin deficiency and an excess of counterregulatory hormones, leading to uncontrolled lipolysis, ketogenesis, and widespread electrolyte and fluid disturbances.Pathophysiology The central event in DKA is a profound loss of insulin action. Without insulin, glucose uptake in insulin-dependent tissues is impaired, while hepatic glucose production...